<DOC>
	<DOC>NCT00080314</DOC>
	<brief_summary>The purpose of this study is to evaluate flexible doses (5-30mg) of aripiprazole versus placebo in patients with bipolar depression.</brief_summary>
	<brief_title>Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>ages 1865 Men and women, who have experienced a prior manic episode that required hospitalization, and now meet criteria for a major depressive episode.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Bipolar 1 Disorder, depressed</keyword>
</DOC>